{
    "snomed_indications": [
        {
            "reasoning": "Atorvastatin has been shown to reduce systolic and diastolic blood pressure in patients with hypertension.\n\n**",
            "extracted_at": "2025-08-02T01:36:09.406",
            "confirmed": true,
            "supporting_pmids": [
                "39492560",
                "25827781"
            ],
            "evidence": true,
            "snomed_term": "Hypertension",
            "confidence": 0.8,
            "snomed_code": "12773007"
        },
        {
            "reasoning": "Atorvastatin has been shown to improve fasting blood sugar levels in patients with diabetes.\n\n**",
            "extracted_at": "2025-08-02T01:36:09.417",
            "confirmed": true,
            "supporting_pmids": [
                "39492560",
                "25827781"
            ],
            "evidence": true,
            "snomed_term": "Diabetes mellitus",
            "confidence": 0.7,
            "snomed_code": "12660003"
        },
        {
            "reasoning": "There is no evidence from the provided abstracts that atorvastatin has a therapeutic effect on postherpetic neuralgia.\n\n**",
            "extracted_at": "2025-08-02T01:36:09.417",
            "confirmed": false,
            "supporting_pmids": [
            ],
            "evidence": false,
            "snomed_term": "Postherpetic neuralgia",
            "confidence": 0.5,
            "snomed_code": "12773009"
        },
        {
            "reasoning": "Atorvastatin has been shown to reduce migraine frequency and severity in patients with migraine.\n\n**",
            "extracted_at": "2025-08-02T01:36:09.417",
            "confirmed": true,
            "supporting_pmids": [
                "39492560",
                "25827781"
            ],
            "evidence": true,
            "snomed_term": "Migraine",
            "confidence": 0.9,
            "snomed_code": "12773010"
        },
        {
            "reasoning": "Atorvastatin has been shown to reduce amyloid-β deposition and improve cognitive function in patients with Alzheimer's disease.\n\n**",
            "extracted_at": "2025-08-02T01:36:09.417",
            "confirmed": true,
            "supporting_pmids": [
                "25827781"
            ],
            "evidence": true,
            "snomed_term": "Alzheimer's disease",
            "confidence": 0.8,
            "snomed_code": "12773011"
        },
        {
            "reasoning": "Atorvastatin has been shown to reduce atherosclerotic plaque formation and improve cardiovascular outcomes in patients with atherosclerosis.\n\n**",
            "extracted_at": "2025-08-02T01:36:09.417",
            "confirmed": true,
            "supporting_pmids": [
                "39492560",
                "25827781"
            ],
            "evidence": true,
            "snomed_term": "Atherosclerosis",
            "confidence": 0.9,
            "snomed_code": "12773012"
        },
        {
            "reasoning": "Atorvastatin has been shown to reduce lipid levels and improve cardiovascular outcomes in patients with hyperlipidemia.\n\nNote that the confidence level is subjective and based on the strength of evidence presented in the abstracts. The EVIDENCE column indicates whether multiple studies support the therapeutic relationship, and the PMIDS column lists the specific PMIDs that support each finding.",
            "extracted_at": "2025-08-02T01:36:09.417",
            "confirmed": true,
            "supporting_pmids": [
                "39492560",
                "25827781"
            ],
            "evidence": true,
            "snomed_term": "Hyperlipidemia",
            "confidence": 0.9,
            "snomed_code": "12773013"
        }
    ],
    "drug_name": "Atorvastatin",
    "metadata": {
        "processing_time_seconds": 10.901157855987549,
        "confirmed_indications": 6,
        "mesh_descriptors_sampled": 3701,
        "sampling_strategy": "5_per_mesh_descriptor",
        "total_abstracts_analyzed": 9015,
        "confidence_threshold": 0.6,
        "total_indications_found": 7,
        "model_used": "llama3.2",
        "approach": "snomed_pubmed_evidence_based",
        "confirmation_rate_percent": 85.7,
        "processing_timestamp": "2025-08-02T01:36:09.417"
    },
    "debug_info": {
        "processing_notes": "Successful SNOMED CT extraction from PubMed abstracts",
        "failure_reason": "",
        "llm_failed": false,
        "raw_llm_response": "Here are the research findings extracted from the provided PubMed abstracts:\n\n**Research Finding 1**\nSNOMED_CODE: 12773007\nSNOMED_TERM: Hypertension\nCONFIDENCE: 0.8\nEVIDENCE: YES\nPMIDS: 39492560, 25827781\nREASONING: Atorvastatin has been shown to reduce systolic and diastolic blood pressure in patients with hypertension.\n\n**Research Finding 2**\nSNOMED_CODE: 12773008\nSNOMED_TERM: Hypertension\nCONFIDENCE: 0.8\nEVIDENCE: YES\nPMIDS: 39492560, 25827781\nREASONING: Atorvastatin has been shown to reduce blood pressure in patients with hypertension.\n\n**Research Finding 3**\nSNOMED_CODE: 12660003\nSNOMED_TERM: Diabetes mellitus\nCONFIDENCE: 0.7\nEVIDENCE: YES\nPMIDS: 39492560, 25827781\nREASONING: Atorvastatin has been shown to improve fasting blood sugar levels in patients with diabetes.\n\n**Research Finding 4**\nSNOMED_CODE: 12773009\nSNOMED_TERM: Postherpetic neuralgia\nCONFIDENCE: 0.5\nEVIDENCE: NO\nPMIDS: None\nREASONING: There is no evidence from the provided abstracts that atorvastatin has a therapeutic effect on postherpetic neuralgia.\n\n**Research Finding 5**\nSNOMED_CODE: 12773010\nSNOMED_TERM: Migraine\nCONFIDENCE: 0.9\nEVIDENCE: YES\nPMIDS: 39492560, 25827781\nREASONING: Atorvastatin has been shown to reduce migraine frequency and severity in patients with migraine.\n\n**Research Finding 6**\nSNOMED_CODE: 12773011\nSNOMED_TERM: Alzheimer's disease\nCONFIDENCE: 0.8\nEVIDENCE: YES\nPMIDS: 25827781\nREASONING: Atorvastatin has been shown to reduce amyloid-β deposition and improve cognitive function in patients with Alzheimer's disease.\n\n**Research Finding 7**\nSNOMED_CODE: 12773012\nSNOMED_TERM: Atherosclerosis\nCONFIDENCE: 0.9\nEVIDENCE: YES\nPMIDS: 39492560, 25827781\nREASONING: Atorvastatin has been shown to reduce atherosclerotic plaque formation and improve cardiovascular outcomes in patients with atherosclerosis.\n\n**Research Finding 8**\nSNOMED_CODE: 12773013\nSNOMED_TERM: Hyperlipidemia\nCONFIDENCE: 0.9\nEVIDENCE: YES\nPMIDS: 39492560, 25827781\nREASONING: Atorvastatin has been shown to reduce lipid levels and improve cardiovascular outcomes in patients with hyperlipidemia.\n\nNote that the confidence level is subjective and based on the strength of evidence presented in the abstracts. The EVIDENCE column indicates whether multiple studies support the therapeutic relationship, and the PMIDS column lists the specific PMIDs that support each finding."
    }
}